*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter - as a primary diagnosis code | T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.25 | |
| Readmission Rate (%) | 24.98 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 101,548 | |
| Total Hospitalizations with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 24 | |
| DRG Share of Total Hospitalizations | 0.31 | |
| % of Total ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter in DRG | 50.0 | |
| Avg LOS at DRG | 4.68 | |
| Avg LOS with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 3.67 | |
| Readmission Rate at DRG | 32.74 | |
| Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 13.79 | |
| Unplanned Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | |
| Total Medicare payments at DRG | $922,969,291 | |
| Total Medicare payments with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $216,756 | |
| Total Medicare payment per Day at DRG | $1,941 | |
| Total Medicare payment per Day with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $2,463 | |
| Total Medicare payment per Hospitalization at DRG | $9,089 | |
| Total Medicare payment per Hospitalization with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $9,032 | |
| Total Medicare Charges at DRG | $4,727,523,206 | |
| Total Medicare Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $705,793 | |
| Avg Charges at DRG | $46,555 | |
| Avg Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $29,408 | |
| Mortality Rate at DRG | 2.95 | |
| Mortality Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | |
| SNF Discharge Rate at DRG | 13.87 | |
| SNF Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | |
| Home Discharge Rate at DRG | 43.04 | |
| Home Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 54.17 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 448 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter in DRG | 5.0 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 3.35 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 23.9 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 15.08 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $2,557,815 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $1,705 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $5,709 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $12,790,847 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $28,551 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 25.67 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 36.61 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 312: SYNCOPE AND COLLAPSE | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 243,742 | ||||
| Total Hospitalizations with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 184 | ||||
| DRG Share of Total Hospitalizations | 0.74 | ||||
| % of Total ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter in DRG | 2.05 | ||||
| Avg LOS at DRG | 2.84 | ||||
| Avg LOS with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 2.99 | ||||
| Readmission Rate at DRG | 16.31 | ||||
| Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 18.6 | ||||
| Unplanned Readmission Rate at DRG | 11.3 | ||||
| Unplanned Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 12.21 | ||||
| Total Medicare payments at DRG | $1,150,233,161 | ||||
| Total Medicare payments with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $853,863 | ||||
| Total Medicare payment per Day at DRG | $1,663 | ||||
| Total Medicare payment per Day with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $1,550 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,719 | ||||
| Total Medicare payment per Hospitalization with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $4,641 | ||||
| Total Medicare Charges at DRG | $6,931,408,244 | ||||
| Total Medicare Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $5,521,319 | ||||
| Avg Charges at DRG | $28,437 | ||||
| Avg Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $30,007 | ||||
| Mortality Rate at DRG | 0.31 | ||||
| Mortality Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 18.06 | ||||
| SNF Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 21.74 | ||||
| Home Discharge Rate at DRG | 53.49 | ||||
| Home Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 52.17 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 310,318 | ||||
| Total Hospitalizations with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 132 | ||||
| DRG Share of Total Hospitalizations | 0.94 | ||||
| % of Total ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter in DRG | 1.47 | ||||
| Avg LOS at DRG | 3.19 | ||||
| Avg LOS with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 3.61 | ||||
| Readmission Rate at DRG | 20.19 | ||||
| Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 12.9 | ||||
| Unplanned Readmission Rate at DRG | 13.62 | ||||
| Unplanned Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | ||||
| Total Medicare payments at DRG | $1,415,392,709 | ||||
| Total Medicare payments with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $624,677 | ||||
| Total Medicare payment per Day at DRG | $1,431 | ||||
| Total Medicare payment per Day with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $1,310 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,561 | ||||
| Total Medicare payment per Hospitalization with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $4,732 | ||||
| Total Medicare Charges at DRG | $7,113,640,596 | ||||
| Total Medicare Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $3,412,023 | ||||
| Avg Charges at DRG | $22,924 | ||||
| Avg Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $25,849 | ||||
| Mortality Rate at DRG | 0.63 | ||||
| Mortality Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 19.76 | ||||
| SNF Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 15.15 | ||||
| Home Discharge Rate at DRG | 50.47 | ||||
| Home Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 54.55 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 149: DYSEQUILIBRIUM | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 231,812 | ||||
| Total Hospitalizations with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 113 | ||||
| DRG Share of Total Hospitalizations | 0.71 | ||||
| % of Total ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter in DRG | 1.26 | ||||
| Avg LOS at DRG | 4.41 | ||||
| Avg LOS with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 4.9 | ||||
| Readmission Rate at DRG | 29.12 | ||||
| Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 29.13 | ||||
| Unplanned Readmission Rate at DRG | 22.82 | ||||
| Unplanned Readmission Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 22.33 | ||||
| Total Medicare payments at DRG | $1,743,376,418 | ||||
| Total Medicare payments with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $842,289 | ||||
| Total Medicare payment per Day at DRG | $1,704 | ||||
| Total Medicare payment per Day with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $1,520 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,521 | ||||
| Total Medicare payment per Hospitalization with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $7,454 | ||||
| Total Medicare Charges at DRG | $8,543,867,896 | ||||
| Total Medicare Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $4,634,077 | ||||
| Avg Charges at DRG | $36,857 | ||||
| Avg Charges with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | $41,010 | ||||
| Mortality Rate at DRG | 2.89 | ||||
| Mortality Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 22.92 | ||||
| SNF Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 30.09 | ||||
| Home Discharge Rate at DRG | 43.02 | ||||
| Home Discharge Rate with ICD T450X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter | 38.05 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 34 |
| BETH ISRAEL DEACONESS MEDICAL CENTER | 330 BROOKLINE AVE | BOSTON | MA | 02215 | 34 |
| BRIGHAM AND WOMEN'S HOSPITAL | 75 FRANCIS ST | BOSTON | MA | 02115 | 33 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | I2510 | Atherosclerotic heart disease of native coronary artery without angina pectoris |
| 2 | E785 | Hyperlipidemia, unspecified |